Great list, lucid. Thanks for that. I have another trigger that causes at least transient brain fog in me; sinus inflammation. This can be brought about either by inhaled allergens or an infection. Allergens seem to act so rapidly that I think there may be more going on there than just a sinus issue. The mention of upregulated cytokines in the wiki may have touched on it. Allergens were mentioned in the list you posted, but they seemed to focus on food allergens, while everything that I'm allergic to is inhaled. I have heard that there is some tissue in the nasal passages that provides a chemical access to the brain in which the normal blood brain barrier does not apply. This would be significant in the case of inhaled small molecules, although most allergens are not small.
When I worked in a moldy building, everyone who was honest said that they were sleepy there. I had to take caffeine pills to function until the mold started giving me anxiety. IL-6 (one of the cytokines you and Lucid mentioned) may be to blame.
I'm in a cleaner climate now, so I no longer have fatigue or anxiety issues. But I still get instant muscle tension whenever I breathe air with allergens. (i.e. whenever I'm inside. I'm that sensitized now.) I don't think that the triggers actually get to the brain. They set off the trigeminal nerve which then dumps neuropeptides into the brain.
Am J Respir Crit Care Med. 1999 Dec;160(6):1943-6.
Nitric oxide and proinflammatory cytokines in nasal lavage fluid associated with symptoms and exposure to moldy building microbes.
Hirvonen MR, Ruotsalainen M, Roponen M, Hyvärinen A, Husman T, Kosma VM, Komulainen H, Savolainen K, Nevalainen A.
Division of Environmental Health, National Public Health Institute, Kuopio, Finland. Maija-Riitta.Hirvonen@ktl.fi
Epidemiological data indicate that living or working in a moldy building is associated with increased risk of respiratory symptoms and disease related to inflammatory reactions, but biochemical evidence linking cause and effect is still scarce. The staff working in a mold-contaminated school, and a reference group without such exposure, were studied. Nasal lavage was performed and health data were collected with a questionnaire at the end of the spring term, after a 2.5-mo summer vacation, and at the end of the fall term. Here we show that concentrations of tumor necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6), and nitric oxide (NO) in nasal lavage fluid were significantly higher in the exposed than in the control subjects at the end of the first exposure period. These inflammatory mediators decreased to reference group concentrations during the period when there was no exposure and the production of NO and IL-6 increased again during the reexposure in the fall term. Reports of cough, phlegm, rhinitis, eye irritation, and fatigue paralleled the changes in the measured inflammatory markers. These results point to an association between inflammatory markers in the nasal lavage fluid, the high prevalence of respiratory symptoms among the occupants, and chronic exposure to molds in the indoor environment.
PMID: 10588610
Where did they find anyone insane enough to agree to be injected with cytokines?
Can J Appl Physiol. 2004 Aug;29(4):411-8.
Acute interleukin-6 administration impairs athletic performance in healthy, trained male runners.
Robson-Ansley PJ, de Milander L, Collins M, Noakes TD.
UCT/MRC Research Unit for Exercise Science and Sports Medicine, Dept. of Human Biology, Univ. of Cape Town, Newlands, South Africa.
Fatigue is an inevitable consequence of physical activity; yet its biological cause remains uncertain. During exercise, a polypeptide messenger molecule interleukin-6 (IL-6) is actively produced. Previously, the administration of recombinant IL-6 (rhIL-6) induced a heightened sensation of fatigue in healthy humans at rest. In contrast, anti-IL-6 receptor antibodies reduced the symptoms of chronic fatigue. In the present study, athletic performance during an exercise challenge consisting of a 10-km running time trial was significantly impaired in trained male runners following the administration of a low dose of rhIL-6 compared to the placebo trial.
PMID: 15317982